“Clinical Safety and Pharmacokinetics of FMX101 4% Topical Minocycline Foam in Pediatric Patients for the Treatment of Moderate-to-Severe Acne Vulgaris”. SKIN The Journal of Cutaneous Medicine 3 (November 9, 2019): S2. Accessed April 19, 2025. https://skin.dermsquared.com/skin/article/view/729.